BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19342995)

  • 1. Hypersensitivity reactions to antineoplastic agents: an overview.
    Syrigou E; Makrilia N; Koti I; Saif MW; Syrigos KN
    Anticancer Drugs; 2009 Jan; 20(1):1-6. PubMed ID: 19342995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hypersensitivity reactions to chemotherapy agents: an overview.
    Syrigou E; Triantafyllou O; Makrilia N; Kaklamanos I; Kotanidou A; Manolopoulos L; Syrigos K
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):206-13. PubMed ID: 20632960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
    Lee C; Gianos M; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
    Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
    J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to chemotherapeutic drugs.
    Shepherd GM
    Clin Rev Allergy Immunol; 2003 Jun; 24(3):253-62. PubMed ID: 12721396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of hypersensitivity reactions to antineoplastic agents.
    Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
    Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.
    Pagani M
    Med Clin North Am; 2010 Jul; 94(4):835-52, xiii. PubMed ID: 20609866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
    Schwartz JR; Bandera C; Bradley A; Brard L; Legare R; Granai CO; Dizon DS
    Gynecol Oncol; 2007 Apr; 105(1):81-3. PubMed ID: 17157366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity of antineoplastic agents.
    Green MR
    West J Med; 1977 Oct; 127(4):292-8. PubMed ID: 72457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses.
    Baldo BA; Pagani M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):565-96, viii. PubMed ID: 25017678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reactions to drugs: evaluation and management.
    Shepherd GM
    Mt Sinai J Med; 2003 Mar; 70(2):113-25. PubMed ID: 12634903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.
    Aroldi F; Prochilo T; Bertocchi P; Zaniboni A
    J Chemother; 2015 Feb; 27(2):63-6. PubMed ID: 25096819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and biotherapy-induced hypersensitivity reactions.
    Van Gerpen R
    J Infus Nurs; 2009; 32(3):157-65. PubMed ID: 19444023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a protocol to minimize hypersensitivity reactions with asparaginase administration.
    Bryant R
    J Intraven Nurs; 2001; 24(3):169-73. PubMed ID: 11530362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infusion reaction and anaphylaxis].
    Yoshida K; Shiono M; Ishioka C
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1753-7. PubMed ID: 22083179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute reactions to chemotherapy agents.
    de Lemos ML
    J Oncol Pharm Pract; 2006 Sep; 12(3):127-9. PubMed ID: 17022867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.